Genetically engineered Bifidobacterium animalis expressing the Salmonella flagellin gene for the mucosal immunization in a mouse model

Journal of Gene Medicine

Volumn 8, Issue 11, 2006, Pages 1341-1346

  Takata, Tetsuo ^a   Shirakawa, Toshiro ^a   Kawasaki, Yoshiko ^a   Kinoshita, Shohiro ^b   Gotoh, Akinobu ^a   Kano, Yasunobu ^c   Kawabata, Masato ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Bifidobacterium animalis; Flagellin; Mucosal vaccine; Salmonella typhimurium

Indexed keywords

FLAGELLIN; IMMUNOGLOBULIN A; PROBIOTIC AGENT; PROTEIN ANTIBODY; TYPHOID VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BIFIDOBACTERIUM ANIMALIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES LEVEL; FEMALE; GENE EXPRESSION; GENETIC ENGINEERING; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; TYPHOID FEVER;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BIFIDOBACTERIUM; ESCHERICHIA COLI; FEMALE; FLAGELLIN; GENES, BACTERIAL; GENETIC ENGINEERING; GENETIC VECTORS; IMMUNITY, MUCOSAL; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SALMONELLA TYPHIMURIUM; VACCINES, SYNTHETIC;

BIFIDOBACTERIUM ANIMALIS; SALMONELLA; SALMONELLA TYPHIMURIUM;

EID: 33751217447     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.963     Document Type: Article

References (28)

1. WHO. Global typhoid burden refined. Bull World Health Org 2004; 82: 319.
2. Wong KH, Feeley JC, Northrup RS, Forlines ME. Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals. Infect Immunol 1974; 9: 348-353.
3. Black R, Levine MM, Young C, et al. Immunogenicity of Ty21a attenuated "Salmonella typhi" given with sodium bicarbonate or in enteric-coated capsules. Dev Biol Stand 1983; 53: 9-14.
4. Canh do G, Lin FY, Thiem VD, et al. Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children. Infect Immunol 2004; 72: 6586-6588.
5. Levine MM, Ferreccio C, Cryz S, Ortiz E. Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. Lancet 1990; 336: 891-894.
6. Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 1999; 17(Suppl 2): S22-S27.
7. Engels EA, Falagas ME, Lau J, Bemish ML. Typhoid fever vaccines: a meta-analysis of studies on efficiency and toxicity. Br Med J 1998; 316: 110-116.
8. Tannock GW. Identification of lactobacilli and bifidobacteria. Curr Issues Mol Biol 1999; 1: 53-64.
9. Kurmann JA, Rasik JL. The health potential of products containing bifidobacteria. In Therapeutic Properties of Fermented Milks, Robinson RK (ed). 1991; 117-157.
10. Ohta T, Nakatsugi S, Watanabe K, et al. inhibitory effects of bifidobacterium-fermented soy milk on 2-amino-1-methyl-6-phenylimidazo[4,5-blpyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones. Carcinogenesis 2000; 21: 937-941.
11. Zhou JS, Gill HS. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis. Int J Food Microbiol 2005; 103: 97-104.
12. Rossi M, Brigidi P, Matteuzzi D. Improved cloningrr vectors for Bifidobacterium. spp. Lett Appl Microbiol 1998; 26: 101-104.
13. Matsumura H, Takeuchi A, Kano Y. Construction of Escherichia coli-Bifidobacterium longum shuttle vector transforming B. longum 105-A and 108-A. Biosci Biotechnol Biochem 1997; 61: 1211-1212.
14. Scalabrini P, Rossi M, Spettoli P, Matteuzzi D. Characterization of Bifidobacterium strains for use in soymilk fermentation. Int J Food Microbiol 1998; 39: 213-219.
15. McClelland M, Sanderson KE, Spieth J, et al. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 2001; 413: 852-856.
16. Tanaka K, Samura K, Kano Y. Structural and functional analysis of pTB6 from Bifidobacterium longum. Biosci Biotechnol Biochem 2005; 69: 422-425.
17. Takeuchi A, Matsumura H, Kano Y. Cloning and expression in Escherichia coli of a gene, hup, encoding the histone-like protein HU of Bifidobacterium longum. Biosci Biotechnol Biochem 2002; 66: 598-603.
18. Nakamura T, Sasaki T, Fujimori M, et al. Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors. Biosci Biotechnol Biochem 2002; 66: 2362-2366.
19. Strindelius L, Filler M, Sjoholm I. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice. Vaccine 2004; 22: 3797-3808.
20. Seegers JF. Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotechnol 2002; 20: 508-515.
21. Garmory HS, Brownb KA, Titball RW. Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol Rev 2002; 26: 339-353.
22. Gibson G, McCartney A, Rastall R. Prebiotics and resistance to gastrointestinal infections. Br J Nutr 2005; 93: 31-34.
23. Saxelin M, Tynkkynen S, Mattila-Sandholm T, Vos WMd. Probiotic and other functional microbes: from markets to mechanisms. Curr Opin Biotechnol 2005; 16: 204-211.
24. Lammers KM, Brigidi P, Vitali B, et al. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 2003; 38: 165-172.
25. Jiang W, Pisetsky D. Enhancing immunogenicity by CpG DNA. Curr Opin Mol Ther 2003; 5: 180-185.
26. Raghavan S, Nyström J, Fredriksson M, Holmgren J, Harandi AM. Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori. Infection Infect Immunol 2003; 71: 7014-7022.
27. Cookson BT, Bevan MJ. Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice. J Immunol 1997; 158: 4310-4319.
28. Moors MA, Li L, Mizel SB. Activation of interleukin-1 receptor-associated kinase by Gram-negative flagellin. Infect Immunol 2001; 69: 4424-4429.